A selective BCL-XL PROTAC degrader achieves safe and potent antitumor activity
University of Florida · The University of Texas MD Anderson Cancer Center · +4 more institutions
Indexed incrossref
Abstract
No abstract available for this paper.
Citation impact
640
total citations
- FWCI
- 21.02
- Percentile
- 100%
- References
- 63
Citations per year
Authors
25Topics & keywords
Topics
Keywords
- Pharmacology
- Computational biology
- Chemistry
- Medicine
- Cancer research
- Biology
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.